Catalyst Wire Dossier Catalyst Wire Dossier

TRI-ESTARYLLA

NORGESTIMATE AND ETHINYL ESTRADIOL · Xiromed, LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TRI-ESTARYLLA, covering 2013-01-30 to 2024-02-01. Get the full timeline:

Most recent: FDA Approved: TRI-ESTARYLLA — Supplemental Application (Xiromed, LLC.)

See pricing